Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Agrium Inc. (NYSE: AGU)(TSX: AGU) shares declined 3.30 percent to close at $87.02 a share Monday. The stock traded between $86.59 and $90.00 on volume of 1.82 million shares traded. The company announced that wholesale EBIT for the third quarter of 2013 is expected to be roughly $200 million lower than a year ago. Shares of Agrium have fallen approximately 13.0 percent year-to-date.
Get more information on Agrium and free access to the in-depth equity report at:
VeriFone Systems Inc. (NYSE: PAY) shares fell 2.54 percent to close at $22.99 a share Monday. The stock traded between $22.91 and $23.80 volume of 2.13 million shares traded. The company has named Paul Galant, former CEO of Citigroup Inc.’s Enterprise Payments, as the new Chief Executive Officer, effective Oct. 1st. Shares of VeriFone Systems have fallen approximately 22.0 percent year-to-date.
Get more information on VeriFone Systems and free access to the in-depth equity report at:
Red Hat Inc. (NYSE: RHT) shares declined 0.54 percent to close at $52.93 a share Monday. The stock traded between $52.00 and $53.41 on volume of 3.01 million shares traded. The company reported revenues were $374 million for the second quarter of fiscal 2014, an increase of 16.0 percent when compared to a year ago.
Get more information on Red Hat and free access to the in-depth equity report at:
Sequenom, Inc. (NASDAQ: SQNM) shares declined 2.44 percent to close at $2.76 a share Monday. The stock traded between $2.73 and $2.82 on volume of 2.99 million shares traded. The company announced that its Board of Directs has authorized "a review of potential strategic alternatives for its Genetic Analysis business segment." Shares of Sequenom have gained approximately 38.0 percent year-to-date.
Get more information on Sequenom and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities